Castle Biosciences (CSTL) Capital Leases (2023 - 2025)
Historic Capital Leases for Castle Biosciences (CSTL) over the last 3 years, with Q3 2025 value amounting to $339000.0.
- Castle Biosciences' Capital Leases rose 1730.1% to $339000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $339000.0, marking a year-over-year increase of 1730.1%. This contributed to the annual value of $311000.0 for FY2024, which is 114400.0% up from last year.
- Castle Biosciences' Capital Leases amounted to $339000.0 in Q3 2025, which was up 1730.1% from $364000.0 recorded in Q2 2025.
- Castle Biosciences' 5-year Capital Leases high stood at $364000.0 for Q2 2025, and its period low was $25000.0 during Q4 2023.
- For the 3-year period, Castle Biosciences' Capital Leases averaged around $281142.9, with its median value being $312000.0 (2024).
- In the last 5 years, Castle Biosciences' Capital Leases skyrocketed by 114400.0% in 2024 and then skyrocketed by 1666.67% in 2025.
- Quarter analysis of 3 years shows Castle Biosciences' Capital Leases stood at $25000.0 in 2023, then skyrocketed by 1144.0% to $311000.0 in 2024, then rose by 9.0% to $339000.0 in 2025.
- Its last three reported values are $339000.0 in Q3 2025, $364000.0 for Q2 2025, and $328000.0 during Q1 2025.